Julie Krop
2017
In 2017, Julie Krop earned a total compensation of $1.3M as Chief Medical Officer and Executive Vice President, Clinical and Regulatory Affairs at AMAG Pharmaceuticals, a 22% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $194,040 |
|---|---|
| Option Awards | $224,392 |
| Salary | $441,885 |
| Stock Awards | $402,150 |
| Other | $8,100 |
| Total | $1,270,567 |
Krop received $441.9K in salary, accounting for 35% of the total pay in 2017.
Krop also received $194K in non-equity incentive plan, $224.4K in option awards, $402.2K in stock awards and $8.1K in other compensation.
Rankings
In 2017, Julie Krop's compensation ranked 7,824th out of 14,666 executives tracked by ExecPay. In other words, Krop earned more than 46.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,824 out of 14,666 | 47th |
Division Manufacturing | 2,935 out of 5,772 | 49th |
Major group Chemicals And Allied Products | 953 out of 2,075 | 54th |
Industry group Drugs | 740 out of 1,731 | 57th |
Industry Pharmaceutical Preparations | 579 out of 1,333 | 57th |
Source: SEC filing on April 25, 2018.
Krop's colleagues
We found four more compensation records of executives who worked with Julie Krop at AMAG Pharmaceuticals in 2017.